Page last updated: 2024-11-04

sumatriptan and Gastroparesis

sumatriptan has been researched along with Gastroparesis in 1 studies

Sumatriptan: A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS.
sumatriptan : A sulfonamide that consists of N,N-dimethyltryptamine bearing an additional (N-methylsulfamoyl)methyl substituent at position 5. Selective agonist for a vascular 5-HT1 receptor subtype (probably a member of the 5-HT1D family). Used (in the form of its succinate salt) for the acute treatment of migraine with or without aura in adults.

Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"Many migraineurs awake early in the morning with their attack progressing and already associated with nausea and vomiting."2.46Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine. ( Freitag, F; Pearlman, SH; Rapoport, AM, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rapoport, AM1
Freitag, F1
Pearlman, SH1

Reviews

1 review available for sumatriptan and Gastroparesis

ArticleYear
Innovative delivery systems for migraine: the clinical utility of a transdermal patch for the acute treatment of migraine.
    CNS drugs, 2010, Volume: 24, Issue:11

    Topics: Clinical Trials as Topic; Drug Administration Routes; Female; Gastroparesis; Humans; Iontophoresis;

2010